Results 131 to 140 of about 17,265 (194)

The Combined Therapeutic Effect of Lenvatinib and ADI-PEG 20 in Advanced Hepatocellular Carcinoma: A Case Report. [PDF]

In Vivo
Yu J, Lin YH, Yeh CT, Lin CL.
europepmc   +1 more source

Treatment for intermediate and advanced-stage hepatocellular carcinoma: does systemic therapy synergize the therapeutic efficacy of TACE? [PDF]

Front Immunol
Li Z, Tan J, Li ZJ, Yan P, Xiang H.
europepmc   +1 more source

Comparison of the efficacy of transarterial chemoembolization combined with radiofrequency ablation or sintilimab and bevacizumab for unresectable hepatocellular carcinoma. [PDF]

BMC Gastroenterol
Li T, Zhao H, Dong C, Song Y, Li M.
europepmc   +1 more source

Changing Treatment Landscape of Hepatocellular Carcinoma: A Real-World Retrospective Analysis of Treatment Algorithms and Outcomes of Patients over 10 Years. [PDF]

Target Oncol
Bathon M, Binder N, Welland S, Gerdes C, Wirth T, Ringe KI, Quante M, Vogel A, Saborowski A.   +8 more
europepmc   +1 more source

Ultrasound localization microscopy for evaluation of therapeutic efficacy assessment after transarterial chemoembolization in hepatocellular carcinoma. [PDF]

Front Oncol
Wang MY, Lei L, Zhang X, Chen F, Li BH, Yao YN, Deng L, Zhang JD, Sun YZ, Lei JQ, Guo S.   +10 more
europepmc   +1 more source

Downstaging therapy of intermediate-stage hepatocellular carcinoma: microwave ablation vs. surgical resection. [PDF]

Front Oncol
Li G, Hu X, Wang H, Liu W.
europepmc   +1 more source

Icaritin plus TACE improves survival in advanced HCC with macrovascular invasion: a multicenter cohort study. [PDF]

Front Immunol
Lu H, Xu T, Li J, Tang B, Zeng Y, Li X, Cun J, Xia X, Hu J, Xie X, Fan H.   +10 more
europepmc   +1 more source

Prognostic Value of Skeletal Muscle Loss in Unresectable Hepatocellular Carcinoma Treated with TACE-Based Combination Therapy. [PDF]

J Clin Med
Yang N, Chen K, Zheng C, Xu P, Pan J, Jin Y, Chen G, Hu W.   +7 more
europepmc   +1 more source

Effects of mindfulness-based stress reduction on perioperative outcomes in patients with advanced hepatocellular carcinoma undergoing transarterial chemoembolization. [PDF]

PLoS One
Zhao Y, Li J, Li X, Zhang M, Qin J.
europepmc   +1 more source

Retrospective Analysis of the Clinical Efficacy, Safety, and Influencing Factors of Drug-Eluting Bead Transarterial Chemoembolization for Unresectable Hepatic Malignancies. [PDF]

Clin Med Insights Oncol
Liu L, Sheng Y, Liang X, Yang T, Dong L, Gao D, Chen B, Xu T, Ai M, Shan H, Tang J, Zhang L, Shi D, Zhu X.   +13 more
europepmc   +1 more source